НовостиBenzingaUBS Initiates Coverage On Odyssey Therapeutics with Buy Rating, Announces Price Target of $27 UBS Initiates Coverage On Odyssey Therapeutics with Buy Rating, Announces Price Target of $27 Benzinga 2026.10.12 13:43 (GMT+0) Открыть на Benzinga Другие новости